News - Drug Development
2012-05-16 02:29:44
MONMOUTH JUNCTION, N.J., May 16, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the appointments of Donald J. Hayden, Jr.
2012-05-14 10:24:30
GREENWOOD VILLAGE, Colo., May 14, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.
2012-05-03 02:31:18
Muscular Dystrophy Association has awarded ReveraGen BioPharma $1.5 million to develop drug TUCSON, Ariz., May 3, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association